A fast way to generate recombinant adenoviruses: A high-frequency- recombination system

Journal of Industrial Microbiology and Biotechnology

Volumn 24, Issue 3, 2000, Pages 198-202

  Steiner, M S ^a   Zhang, Y ^a   Lu, Yi ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Gene therapy; In vivo recombination; LacZ; Shuttle vector

Indexed keywords

BETA GALACTOSIDASE;

ADENOVIRUS; ARTICLE; GENE THERAPY; HUMAN; HUMAN CELL; MARKER GENE; POLYMERASE CHAIN REACTION; RECOMBINANT DNA TECHNOLOGY; SHUTTLE VECTOR; VIRUS PLAQUE; VIRUS RECOMBINANT;

EID: 0034095488     PISSN: 13675435     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jim.2900809     Document Type: Article

References (17)

1. 1 Arbuthnol PB, M-P Bralet, C Le Jossic, J-F Dedieu, M Perricaidet, C Brechot und N Ferry. 1996. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther 7: 1503-1514.
2. 2 Berkner KL. 1988. Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6: 616-629.
3. 3 Bett AJ, W Haddara, L Prevec and FL Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early region 1 and 3. Proc Natl Acad Sci USA 91: 8802-8806.
4. 4 Csete ME, PY Benhamou, KE Drazan, L Wu, DF McIntee, R Afra. Y Mullen, RW Busuttil and A Shaked. 1995. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplant 59: 263-268.
5. 5 Graham FL and L Prevec. 1992. Adenovirus-based expression vectors and recombinant vaccines. Bio Technology 20: 363-390.
6. 6 Graham FL, J Smiley, WC Russell and R Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-72.
7. 7 Hashimoto M, J Aruga, Y Hosoya, Y Kanegae, I Saito and K Mikoshiba. 1996. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum Gene Ther 7: 149-158.
8. 8 Kingston RE. 1993. Calcium phosphate transfection. In: Current Protocols in Molecular Biology (Ausubel FM, R Brent, RE Kingston, DD Moore, JG Seidman, JA Smith and K Struhl, eds), pp 9.1.4-9.1.9, John Wiley & Sons, New York.
9. 9 Kozarsky KF and JM Wilson. 1993. Gene therapy: adenovirus vectors. Curr Opin Genet Develop 3: 499-503.
10. 10 Lu Y, J Carraher, Y Zhang, J Armstrong. J Lerner, WP Rogers and MS Steiner. 1999. Delivery of adenoviral vectors to the prostate for gene therapy. Cancer Gene Ther 6: 64-72.
11. 11 Lu Y, Y Zhang and MS Steiner. 1998. Efficient identification of recombinant adenoviruses by direct plaque-screening. DNA Cell Biol 17: 643-645.
12. 12 Marini F, FA Ghosh, E Bakina, A Nelson and D Farquhar. 1997. E. coli lacZ as a suicide gene for anticancer prodrug activation. Proc Am Assoc Cancer Res 38: 342. (Abstract No. 2294).
13. 13 McGrory WJ, DS Bautista and FL Graham. 1988. A simple technique for rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 1: 614-617.
14. 14 Mitchell MF, K Hamada, KJ Sastry, A Sarkar, G Tortolero-Luna, JT Wharton and JA Roth. 1996. Transgene expression in the rhesus cervix mediated by an adenovirus expressing β-galactosidase. Am J Obstet Gynecol 174: 1094-1101.
15. 15 Steiner MS, Y Zhang, J Carraher and Y Lu. 1999. In vivo expression of prostate specific adenoviral vectors in a canine model. Cancer Gene Ther 6: 456-464.
16. 16 Trapnell BC and M Gorziglia. 1994. Gene therapy using adenoviral vectors. Curr Opin Biotech 5: 617-625.
17. 17 Zhang Y, R Stein, W Wang, MS Steiner and Y Lu. 1999. Comparison of prostate specific adenoviral vectors for prostate cancer gene therapy. Tumor Targeting 4: 1-12.